Acadia Pharmaceuticals lobbies on its own behalf. For Q3 2026 it reported $440K across 1 client report and lists 2 lobbyists across its filings. Issues include Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code and Trade (domestic/foreign).
| Client | Reported | Issues |
|---|---|---|
| ACADIA PHARMACEUTICALS | $440K | Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $1.74M | 1 |
| 2025 | $2.28M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.